To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
- PMID: 32241791
- DOI: 10.1136/annrheumdis-2020-217367
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
Keywords: communicable diseases, imported; hydroxychloroquine; immune system diseases; social work.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?Ann Rheum Dis. 2021 Feb;80(2):e19. doi: 10.1136/annrheumdis-2020-217570. Epub 2020 Apr 21. Ann Rheum Dis. 2021. PMID: 32317315 No abstract available.
-
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.Ann Rheum Dis. 2021 Jan;80(1):e8. doi: 10.1136/annrheumdis-2020-217557. Epub 2020 Apr 22. Ann Rheum Dis. 2021. PMID: 32321722 No abstract available.
Comment on
-
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4. Cell Res. 2020. PMID: 32020029 Free PMC article. No abstract available.
-
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237. Clin Infect Dis. 2020. PMID: 32150618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous